ADIPOQ and obesity due to melanocortin 4 receptor deficiency: Several other investigations have confirmed the association between obesity and the methylation status of LEP and ADIPOQ, which has been proposed to promote obesity-associated insulin resistance and metabolic derangements [13,14,15].